Author

Mark R. Burns

Aminex Therapeutics (United States)ORCID 0000-0002-2810-267XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Angelika Bongers· 1 shared Arthur SchoofsiD· 1 shared Ayu Karsa· 1 shared Chelsea MayohiD· 1 shared Chris Van den HauteiD· 1 shared Dayna SpurlingiD· 1 shared Emma RoncaiD· 1 shared Klaartje SomersiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angelika Bongers

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular OncologyPeer-reviewedFeb 21, 2025

The polyamine transporter ATP13A3 mediates DFMO-induced polyamine uptake in neuroblastoma

Mujahid Azfar, Weiman Gao, Chris Van den Haute…·Klaartje Somers

This study identifies ATP13A3 as a polyamine transporter mediating DFMO-induced polyamine uptake in neuroblastoma, highlighting it as a therapeutic target.

18 citationstop 5%

humanproteomics

𝕏 PostBluesky